Texas 2023 - 88th Regular

Texas House Bill HR1123 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New	Differences
1	1	H.R. No. 1123
2	2
3	3
4	4	R E S O L U T I O N
5	5	WHEREAS, Dr. Michael J. Keating, a clinical professor and
6	6	researcher who has earned acclaim for his transformative
7	7	contributions to the treatment of chronic lymphocytic leukemia, is
8	8	retiring in 2023, after nearly five decades of service at The
9	9	University of Texas MD Anderson Cancer Center; and
10	10	WHEREAS, During the last 30 years of his career, Dr. Keating
11	11	has dedicated himself to the study of chronic lymphocytic leukemia
12	12	(CLL) in hopes of improving survival rates and one day developing a
13	13	cure for the disease; his research has yielded groundbreaking
14	14	findings related to the use of fludarabine to treat CLL patients,
15	15	and in only a few decades, the efforts of Dr. Keating and other
16	16	researchers have revolutionized the medical community's
17	17	understanding of CLL and helped improve the complete remission rate
18	18	from this type of cancer from 5 percent to more than 50 percent; and
19	19	WHEREAS, While survival rates for CLL have greatly increased,
20	20	Dr. Keating has remained committed to the search for a cure for CLL,
21	21	which has resulted in the development of highly effective,
22	22	low-toxicity drugs that are in common use today; he established the
23	23	CLL Global Research Foundation, which to date has provided more
24	24	than $31 million to researchers all over the world who are making
25	25	significant strides in CLL research; and
26	26	WHEREAS, Dr. Keating has been recognized with numerous
27	27	accolades for his achievements, including the Service to Mankind
28	28	Award from the Leukemia and Lymphoma Society of America in 1988; he
29	29	was also a recipient of the Charles A. LeMaistre Outstanding
30	30	Achievement Award in Cancer and the Rai Binet Medal in 2002 and was
31	31	honored by his peers as one of the "Giants of Cancer Care" in 2018;
32	32	along the way, he has earned the admiration of his patients for his
33	33	warmth, empathy, and optimism; and
34	34	WHEREAS, A native of Melbourne, Australia, Dr. Keating
35	35	obtained a medical degree from the University of Melbourne in 1966;
36	36	he completed medical residencies in Australia before coming to the
37	37	United States to serve as a Fellow at MD Anderson Cancer Center in
38	38	1974; in all his endeavors, he enjoys the support of a loving family
39	39	that includes his fiancée, Shari, his four children, and his five
40	40	grandchildren; and
41	41	WHEREAS, Dr. Michael Keating's tireless dedication to his
42	42	profession has made him a champion for patients with CLL and a
43	43	driving force in CLL research, and his many accomplishments will
44	44	continue to resonate in the years to come; now, therefore, be it
45	45	RESOLVED, That the House of Representatives of the 88th Texas
46	46	Legislature hereby congratulate Dr. Michael J. Keating on his
47	47	retirement from The University of Texas MD Anderson Cancer Center
48	48	and extend to him sincere best wishes for the future; and, be it
49	49	further
50	50	RESOLVED, That an official copy of this resolution be
51	51	prepared for Dr. Keating as an expression of high regard by the
52	52	Texas House of Representatives.
53	53	A. Johnson of Harris
54	54	______________________________
55	55	Speaker of the House
56	56	I certify that H.R. No. 1123 was adopted by the House on April
57	57	28, 2023, by a non-record vote.
58	58	______________________________
59	59	Chief Clerk of the House